Osteoarthritis
📧 Sign up to get email alerts when something new happens for Osteoarthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-08-29Clinical Trial Update: Phase II Study to Assess Safety and Efficacy of SL-1002 for Osteoarthritic Knee Pain [Phase 2]
Phase II study update for SL-1002 evaluating safety and efficacy in osteoarthritis-related knee pain.
-
CLINICAL_TRIALS trial_result · 2023-08-18Clinical Trial Update: A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity [Phase 1, Phase 2]
Clinical trial update for a hip flexion feedback system evaluating exercise monitoring in individuals with osteoarthritis and obesity (Phase…
-
FDA approval · 2023-08-17FDA Approved: OXAPROZIN — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for Oxaprozin submitted by Dr. Reddy's Laboratories Limited.
-
CLINICAL_TRIALS trial_result · 2023-08-15Clinical Trial Update: Efficacy of Probiotics for NSAID-induced Enteropathy in Arthritis Patients [Phase 2]
Phase 2 trial evaluating the efficacy of probiotics for NSAID-induced enteropathy in osteoarthritis patients.
-
CLINICAL_TRIALS trial_result · 2023-08-08Clinical Trial Update: Single-use Efficiency Instruments With Patient Specific Technique (MyKnee®) Versus Traditional Metal Instruments With Conventional Surgical Technique [NA]
Clinical trial comparing single-use efficiency instruments with patient-specific technique (MyKnee) versus traditional metal instruments wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES) [Phase 3]
Multicenter Phase 3 trial of stem cell therapy for osteoarthritis has completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-07-17Clinical Trial Update: Efficacy and Safety of S (+) - Ibuprofen in Osteoarthritis Pain [Phase 2]
Phase 2 trial update evaluating efficacy and safety of S (+)-Ibuprofen in osteoarthritis pain has been completed.
-
CLINICAL_TRIALS trial_result · 2023-07-06Clinical Trial Update: Efficacy and Safety of SKCPT in Patients With Knee Osteoarthritis: Phase III Clinical Trial [Phase 3]
Phase III trial update evaluating efficacy and safety of SKCPT in knee osteoarthritis has completed.
-
FDA approval · 2023-06-07FDA Approved: MELOXICAM — Original Application (XLCare Pharmaceuticals, Inc.)
The FDA approved the original application for MELOXICAM (meloxicam), a generic version manufactured by XLCare Pharmaceuticals, Inc., under A…
-
FDA label_change · 2023-05-10FDA Approved: METHYLPREDNISOLONE ACETATE — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for methylprednisolone acetate by Sandoz Inc.
-
FDA approval · 2023-05-05FDA Approved: IBUPROFEN — Supplemental Application (Winco Foods, LLC)
The FDA approved a supplemental application for a generic ibuprofen product developed by Winco Foods, LLC.
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: Weight Loss and Exercise for Communities With Arthritis in North Carolina [NA]
A completed clinical trial evaluating weight loss and exercise effects in adults with osteoarthritis in North Carolina; results posted in 20…
-
FDA approval · 2023-02-21FDA Approved: VOLTAREN ARTHRITIS PAIN — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Voltaren Arthritis Pain (diclofenac sodium) submitted by Haleon US Holdings LLC. This action…
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System [NA]
A terminated randomized trial update for the Vanguard XP Bicruciate Knee System with posted results, investigating knee arthroplasty outcome…
-
CLINICAL_TRIALS trial_result · 2023-02-14Clinical Trial Update: Prospective Multicenter Post Approval Study of the LPS-Flex Mobile Bearing Knee [NA]
Prospective multicenter post-approval study of the LPS-Flex mobile bearing knee has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-02-09Clinical Trial Update: Study of CG100649 Versus Celecoxib in Osteoarthritis Patients [Phase 2]
Phase 2 trial comparing CG100649 to celecoxib in osteoarthritis has completed with results posted.
-
FDA approval · 2023-02-03FDA Approved: PIROXICAM — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for piroxicam from Strides Pharma Science Limited. This action completes another regulatory submissi…
-
CLINICAL_TRIALS trial_result · 2023-01-19Clinical Trial Update: Aequalis Pyrocarbon IDE; Replacing the Humeral Head in Hemi-Arthroplasty
Completed clinical trial of Aequalis Pyrocarbon IDE for replacing the humeral head in hemi-arthroplasty, with results posted in 2023.
-
CLINICAL_TRIALS research · 2022-12-27Clinical Trial Update: Imaging Biomarkers of Knee Osteoarthritis [NA]
Clinical trial update on imaging biomarkers for knee osteoarthritis; study status completed with results posted.
-
FDA approval · 2022-12-22FDA Approved: DICLOFENAC SODIUM AND MISOPROSTOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for the fixed-dose combination diclofenac sodium and misoprostol from Mylan Pharmaceuticals Inc. The…
-
FDA approval · 2022-11-23FDA Approved: VOLTAREN ARTHRITIS PAIN — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for Voltaren Arthritis Pain (diclofenac sodium) from Haleon US Holdings LLC to expand the labeling f…
-
FDA approval · 2022-11-15FDA Approved: CAREONE IBUPROFEN — Supplemental Application (American Sales Company)
The FDA approved a supplemental application for CAREONE IBUPROFEN (ibuprofen) filed by American Sales Company under ANDA077349.
-
CLINICAL_TRIALS trial_result · 2022-11-10Clinical Trial Update: A Safety, Tolerability and Pharmacokinetic Dose Escalation Study of HC-ER in Patients With Osteoarthritis Pain [Phase 2]
Phase 2 study evaluating safety, tolerability, and pharmacokinetics of HC-ER in patients with osteoarthritis pain has completed.
-
FDA approval · 2022-11-09FDA Approved: DAYPRO — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Daypro (oxaprozin) from Pfizer Laboratories Div Pfizer Inc, indicating an approved update re…
-
FDA approval · 2022-10-28FDA Approved: NAPROXEN SODIUM — Original Application (Camber Consumer Care Inc)
FDA approved Naproxen Sodium generic from Camber Consumer Care Inc under an Original Application (ANDA211065).